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Minors Held by Majors: The H13 Minor
Histocompatibility Locus Defined as a
Peptide/MHC Class I Complex
Interest in minor H loci has endured not only because
they are relevant to clinical transplantation but also be-
cause their antigens have served as important models
to understand the role of self and foreign peptides on
the thymic and peripheral T cell repertoire (Bevan, 1975;
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von Boehmer and Kisielow, 1990; Auchincloss and Sultan,University of California
1996; Goulmy, 1996). Why minor H loci serve as trans-Berkeley, California 94720
plantation barriers is not well understood. Possible ex-2The Jackson Laboratory
planations include their influence on antigen processingBar Harbor, Maine 04609
and presentation, on the development of the T cell reper-
toire, or on peripheral immune responsiveness (Love-
land and Lindahl, 1991; Roopenian, 1992). For example,Summary
the minor H alleles could differ in their transcriptional regu-
lation, leading to the presence or absence of the antigenThe products of minor histocompatibility (H ) loci are
precursor proteinand as a result the processed H peptide/serious barriers to tissue transplantation even among
MHC complex itself. Differences in peptide/MHC display,major histocompatibility complex (MHC) identical indi-
despite equivalent expression, could also result from vari-viduals, frequently causing chronic graft rejection and
ations in the suitability of the polymorphic donor proteinsgraft versus host disease. Over 50 minor H loci map
for the antigen processing pathway (York and Rock, 1996).to mouse autosomal chromosomes but none are
Alternatively, structurally related allelic H peptides couldknown at the molecular level. By expression cloning,
act as altered agonist/antagonists and influence the pe-we identified the H13 locus, a classical minor H locus
ripheral T cell responsiveness or T cell development in thefirst detected 30 years ago by the trait of graft rejec-
thymus (Allen, 1994; Jameson and Bevan, 1995; Jamesontion. The H13a allele is located on chromosome 2 and
et al., 1995). Determining which of these or even moreencodes a novel protein that yields the rare naturally
complex hypotheses account for the immunobiology ofprocessed nonapeptide SSVVGVWYL (SVL9) for pre-
minor H antigens requires the identification of their genessentation by the Db MHC class I molecule. The SVL9
and processed peptide products.peptide binds Db MHC despite the absence of the con-
Minor H antigens can in principle be identified bysensus binding motif, and a conservative methyl group
positional cloning techniques wherein detailed geneticsubstitution (Valine 4 ↔ Isoleucine) explainswhy recip-
information of the defined chromosomal location leads
rocal T cell responses are elicited in H13a and H13b
to their discovery. Indeed knowledge of the mitochon-
congenic strains.
drial origin of maternally transmitted H antigens did lead
to the discovery of the antigenic precursors as the ND1,
COI, and ATPase6 proteins from among the 13 encodedIntroduction
by the mitochondrial genome (Loveland et al., 1990;
Morse et al., 1996; Bhuyan et al., 1997). The N-formyl-
Minor histocompatibility (H) antigens cause graft versus
ated peptides from these proteins were presented by
host disease (GVHD) and chronic graft rejection in a
the nonpolymorphic H2-M3 MHC class 1b molecule and
large percentage of transplantation cases, even when
other peptides by the conventional MHC class I mole-
the donor and recipient tissues share the same major
cules (Dabhi and Lindahl, 1996; Bhuyan et al., 1997).
histocompatibility complex (MHC) antigens (Goulmy et Likewise, prior knowledge that the HY loci mapped to
al., 1996). The genetic polymorphisms responsible for
the Y chromosome facilitated the identification of the
minor H antigens have been studied for over 80 years
Smcy and Uty genes as the source of the mouse male-
(Little, 1914) and have resulted in the delineation of over
specific H antigens (King et al., 1994; Scott et al., 1995;
50 autosomaland sex-linked loci based upon their inher- Greenfield et al., 1996). Positional cloning approaches
itance and segregation patterns in recombinant and are, however, orders of magnitude more difficult for the
congenic mice (Little, 1941; Snell, 1948; Doolittle et al., gene-rich autosomal chromosomes that harbor the great
1996). It is very likely that the significant clinical prob- majority of minor H loci.
lems associated with tissue graft rejection result from Biochemical purification of the antigenic peptide pro-
the existence of a similar number of H loci in humans. vides an alternative approach to identifying T cell±
The minor H antigens do not normally induce antibody stimulating peptides (Falk et al., 1991b; Jardetzky et al.,
responses but rather serve as the source of processed 1991; Hunt et al., 1992). This peptide purification/mass
peptides presented by MHC molecules to T cells (Wallny spectrometry approach, in combination with prior knowl-
and Rammensee, 1990). The rejection phenotype con- edge of DNA sequence, was successful in identifying
ferred by minor H loci is thus the result of a T cell re- the HY peptides from the human homolog of the Smcy
sponse elicited by qualitative or quantitative differences gene (Wang et al., 1995b; Meadows et al., 1997). Similar
in the antigenic peptide display of the MHC molecules methods were also successful in identifying a peptide
on the donor and/or host cell surface. recognized by a T cell obtained from a GVHD patient
(den Haan et al., 1995) and another peptide that could
induce GVHD in mice (Perreault et al., 1996). However,*To whom correspondence should be addressed.
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the donor proteins for either of these two antigenic pep-
tides are unknown. Whether these antigens represent
products of polymorphic H loci therefore remains ob-
scure, as does the molecular mechanism of their anti-
genicity.
Here we apply an expression cloning strategy to de-
fine the classical autosomal mouse minor histocompati-
bility locus, H13, at the molecular level. This locus was
originally detected by Snell three decades ago as caus-
ing tissue incompatibility between inbred mouse strains
(Snell et al., 1967). Our strategy allows screening of a
cDNA library in recipient cells with lacZ-inducible, antigen-
specific T cells as a specific probe for expression of
the appropriate peptide/MHC complex (Karttunen et al.,
1992; Malarkannan et al., 1995a; Shastri, 1996). The H13a
cDNA encodes a previously unknown protein that yields
the naturally processed nonapeptide SSVVGVWYL (SVL9)
as the minor histocompatibility antigen bound to the Db
MHC molecule. Intriguingly, the H13a SVL9 peptide does
not conform to the Db MHC consensus binding motif
and differs from its H13b homolog SSVIGVWYL (SIL9)
by a single conservative methyl group substitution. Nev-
ertheless, both SVL9 and SIL9 peptides bind Db MHC
and are detected as dominant antigens in reciprocal
anti-H13a and anti-H13b immunizations. These findings
provide new insights into the nature and immunological
role of naturally processed minor H peptides.
Figure 1. The 30NX/B10Z T-Cell Hybrid Recognizes a Db MHC-
Associated Polymorphic Antigen Expressed in the B6, but LackingResults
in the BALB Background
(A) B6 or (BALB/c 3 BALB.b)F1 spleen cells were cultured withDerivation of the H13a-Specific lacZ
ConA and LPS for 48 hr. After three washes, the indicated numberInducible T Cell Hybrid
of blast cells were cocultured overnight with 1 3 105 30NX/B10Z or
The CTL line 30NX/B10-1 was obtained from B10.CE the control Kb-restricted 18.5Z T cell hybrids. The T cell response
(30NX)-H13b mice immunized with spleen cells from the was measured as the lacZ activity by conversion of the substrate
congenic C57BL/10 (B10, H13a) mice (Cariappa et al., chlorophenol red b-pyranoside (CPRG) at 595 nm and 655 nm as
reference.1996). These two strains differ in a segment of chromo-
(B) The lacZ response of 30NX/B10Z T cells to the B6-derived EL-4some 2 that includes the H13 locus (Graff et al., 1977).
cell line was tested in the presence of indicated dilutions of anti-DbThis cytotoxic T lymphocyte (CTL) line recognizes the
MAb, B22.249, or anti-Kb MAb, Y3. As a control, the same two
H13a antigen in association with the Db MHC molecule antibodies were included in cultures of the Kb-restricted T cell hybrid
(data not shown). As a first step toward identification of F1/5R-5Z and B6 blasts.
the antigen, the CTLs were fused with the BWZ.36/CD8
fusion partner to obtain the b galactosidase (lacZ)± lacZ inducible 30NX/B10Z T cell hybrid was used as a
inducible hybrid designated30NX/B10Z (Sanderson and probe for expression of the cognate ligand in Db-expressing
Shastri, 1994). The lacZ response in the hybridoma was recipient cells that were transiently transfected with
induced by splenic blasts of C57BL/6 (B6) mice, or by pools of a plasmid cDNA expression library prepared
EL4 cells, a thymoma cell line of B6 origin. The response from the EL-4 cell line (Karttunen et al., 1992; Malarkannan
was inhibited by anti-Db but not anti-Kb monoclonal anti- et al., 1995a). Representative data from one of twelve 96-
body (MAb; Figures 1A and 1B, left panels). As a reciprocal well plates show a cDNA pool with above background
control, the anti-Kb, but not anti-Db, MAb inhibited the T cell±stimulating activity (Figure 2A). Indeed, several
response of F1/5R-5Z T cells that recognize a Kb-bound active plasmid clones from this pool were obtained after
peptide (Figure 1B, right panel). The 30NX/B10Z cells fractionating the mixture into individual colonies (Figure
did not respond to blasts from the H13b (BALB/c 3 2B). One of these plasmids, designated 47c1, was fur-
BALB. B)F1 (H-2dxb) mice, even though these blasts were ther tested for its ability to stimulate the 30NX/B10Z
fully capable of stimulating another T cell hybrid, 18.5Z T cells in an antigen-specific and MHC-restricted man-
(Figure 1A). The 30NX/B10Z T cell hybrid therefore dis- ner. The recipient cells generated the T cell±stimulating
played the same H13a-specific, Db-restricted reactivity ligand, in a dose-dependent manner, only with the 47c1
as did the parent CTL line. plasmid DNA when it was cotransfected with the cDNA
encoding the Db, but not the Kb, MHC molecule (Figure
2C). We conclude that the 47c1 cDNA clone allowedExpression Cloning the H13 cDNA
The cDNA clone 47c1, encoding the Db-restricted anti- expression of an antigen recognized by the 30NX/B10Z
T cell.genic activity, was isolated by expression cloning. The
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Figure 2. Isolation of the cDNA Clone Encod-
ing the Antigen Presented by the Db MHC to
30NX/B10Z T Cells
(A) Pools of plasmid DNAs from an EL-4 cDNA
library were transiently transfected intoLMtk-
fibroblasts together with cDNA clonesencod-
ing Db MHC and B7.2 in 96-well plates. Two
days later, the 30NX/B10Z T cells were
added, and their lacZ response was mea-
sured as in the legend to Figure 1. Ab-
sorbance data are shown for one of twelve
96-well plates screened.
(B) Response of T cells to the recipient cells
transfected as above but with plasmid DNA
from individual colonies isolated from the
positive pool. Clone 47c1 was selected for
further study.
(C) Recipient LMtk- cells were transfected
with varying concentrations of the 47c1 plas-
mid or the vector DNA together with cDNA
encoding either the Db or Kb MHC molecules.
The 47c1 cDNA Clone Maps to the H13 is a mouse chromosome 2 gene that is located within
1.06 6 1.06 cM of a and 0.53 6 0.53 cM of D2Mit22.Locus on Chromosome 2
Genetic studies of allograft rejection and the analysis
of CTL activity in vitro have mapped the H13 locus to Location of the Antigenic Activity
within the H13 cDNA Clonemouse chromosome 2 between a proximal H locus, H3b,
and agouti (a; Snell et al., 1967; Roopenian et al., 1993; The minimal sequence required to confer antigenic ac-
tivity within the 47c1 cDNA was defined by testing theD. R., unpublished data). To distinguish the possibilities
that the 47c1 cDNA clone was derived from the H13 functional activity of deletion constructs. Initially, 39 dele-
tions were generated in the 47c1 cDNA byPCR.A series ofantigen gene itself, a gene that regulates H13 antigen
expression, or an unrelated gene that encodes a cross- reverse PCR primers, together with the vector-encoded
forward primer, were used to amplify DNA fragmentsreactive antigen, we performed genetic mapping stud-
ies. Southern blot restriction fragment length polymor- lacking the C-terminal codons of the H13 gene. The DNA
fragments were recloned into the pcDNAI expressionphism (RFLP) analysis was carried out using mouse
strains previously typed for H13 polymorphisms as well vector, and theplasmid DNAs were tested for their ability
to generate the peptide/Db ligand for the 30NX/B10Z Tas a panel of chromosome 2 congenic strains. With
XbaI-digested DNA, unique RFLP bands hybridizing to cells (Figure 4A). As judged by the ability of the DNA
constructs to generate the 30NX/B10Z T cell response,the 47c1 probe were detected in the H13a strain C57BL/
10 (B10), z9 kb, versus the z14 kb fragment in the H13b the antigenic activity was encoded within or overlapped
the 108 nucleotides represented by the DR4 and thestrains (CE/J or LP/J; Figure 3A). The prototypic H13b
congenic strain, B10. CE(30NX)-H13b, which was used to DR8 constructs (Figure 4B). Because the antigenic activity
was presented by the Db MHC molecule that binds pep-generate the anti-H13a T cell response, clearly contained
the 14kb RFLPband that was identical insize to the H13b tides with the consensus motif XXXXNXX[I,L,M] (Falk et
al., 1991b) and peptides encoded within different trans-strains, CE/J and LP/J. Furthermore, B10.LP-congenic
strains previously used to segregate the H3a, H3b, and lational reading frames can be presented by MHC mole-
cules (Shastri and Gonzalez, 1993; Malarkannan et al.,H13 loci showed an RFLP pattern that was remarkably
consistent with the known distribution of H13 alleles 1995a; Wang et al., 1996), we tested minigene con-
structs representing the only two 9mer sequences con-(Graff et al., 1977; Figure 3B).
The 47c1 cDNA was mapped at a higher resolution taining either a complete (Db1) or a partial Db motif (Db2;
Figure 4A). The Db1 (nucleotides 65±91) and Db2 (nucleo-using DNA samples from an interspecific mouse back-
cross. Polymerase chain reaction (PCR) primers that tides 97±123) motifs are encoded within the second and
the first translational reading frames (Figure 5A). How-amplified the 39 end of 47c1 revealed a sequence poly-
morphism (SSLP) that was used to type DNAs from The ever, the activity of both minigene constructs was indis-
tinguishable from the vector alone (Figure 4B), stronglyJacksonLaboratory Backcross Panel (http://www.jax.org/
resources/documents/cmdata/). The panel consists of 94 suggesting that theH13 antigenic activity was not repre-
sented by a motif-bearing peptide.(B6 3 SPRET/Ei) 3 B6 (BSB) and 94 (B6 3 SPRET/Ei) 3
SPRET/Ei (BSS) backcross DNAs previously typed for We then generated another set of PCR deletions at
the 39 end of the 47c1 clone (Figure 5A). The presencea large number of genetic markers. As summarized in
Figure 3C, the 47c1 cDNA cosegregated with D2Mit22 of the antigenic activity in the DR7, but its loss in the
DR11 construct, indicated that the antigenic peptidein 192 informative backcross mice, hence mapping 47c1
to the interval expected for the H13 locus defined by was either contained entirely within or overlapped the
C-terminus of the DR7 polypeptide (Figure 5B). Indeedthe graft rejection trait. Taken together, these results prove
that the H13 locus, represented by the 47c1 cDNA clone, the minigene construct MSVL10, encoding only the 10
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Figure 4. Location of the H13 Antigenic Activity within the 47c1
cDNAClone Maps to 108Nucleotides but Not to the Peptides Match-
ing the Db Consensus Motif.
(A) Schematic of the expression constructs used to locate the 30NX/Figure 3. Chromosomal Localization of the 47c1 cDNA
B10Z T cells stimulating activity within the 47c1 cDNA clone. The
(A) Southern blot RFLP analysis of H13a and H13b mouse strains.
lines indicate the location of the deletion fragments relative to the
High molecular weight DNA from the mouse strains shown above
original 47c1 cDNA. The residues shown as Db1 and Db2 are the onlyeach lane was digested with XbaI, fractionated, transferred to nitro-
two sequences, encoded within the translational reading frames ofcellulose filters, and probed with radiolabeled fragment of 47c1
the antigenically active fragment that resembles the Db consensusDNA. The 9 kb and the z14 kb bands segregate with the a and b
motif XXXX[N]XXX[I,L,M].alleles of the H13 locus represented by the mouse strains shown.
(B) T cell responses induced by Db1 recipient cells that were tran-(B) Schematic representation of the chromosome 2 region of H3 and
siently transfected with varying amounts of plasmid DNA of theH13 congenic mice analyzed by RFLP in (A). Black boxes represent
indicated expression constructs shown in (A). The transfection con-congenic donor segments, and open box represents a segment of
ditions and measurement of the T cell response were the same asunknown heritage. Relative locus positions and distances (in cM)
in the legends to Figures 1 and 2.are based on earlier mapping studies (Graff et al., 1977; Roopenian
et al., 1993) andthe current mousegenome database (website http://
www.informatics.jax.org/encyclo.html). than the SVL10 peptide in stimulating the 30NX/B10Z T
(C) Positioning of the 47c1 cDNA relative to other loci on mouse
cells (Figure 5C). The ability of SVL9 to stimulate T cellschromosome 2 based on SSLP analysis of The Jackson Laboratory
at pico- to femtomolar concentrations is a defining char-interspecific BSB and BSS backcross panels. N, number of meioses
acteristic of naturally processed peptides presented byanalyzed.
MHC class I molecules (Rotzschke et al., 1990a;Van Bleek
and Nathenson, 1990). In contrast, the same SVL9 pep-
tide failed to stimulate Lpa/2RZ, another H3aa-specific,SSVVGVWYLL residues and an additional methionine co-
don for translational initiation, was as active as the 47c1 Db-restricted T cell hybrid at even 100,000-fold higher
concentration. Note that, except for the C-terminal leu-cDNA. However, another MSVL9 (Met-SSVVGVWYL) con-
struct lacking thesecond C-terminal leucine residue was cine residue, the SVL9 peptide bears no resemblance
to the consensus motif, XXXX[N]XXX[I,L,M], defined for100- to 1000-fold more active than either the MSVL10
or the 47c1 cDNA constructs (Figure 5B). Thus, SVL9 the Db MHC molecule (Falk et al., 1991b). We conclude
that despite this apparent handicap, the SVL9 peptiderather than SVL10 was likely to represent the naturally
processed H13 peptide. simulates the antigenic H13a/Db complex recognized by
the 30NX/B10Z T cells.Further direct evidence that the H13 antigenic activity
was defined by the SVL9 sequence was obtained with To define the donor protein for the H13 antigenic pep-
tide, z1.5 kb of available sequence of the 47c1 cDNAsynthetic peptides. Both synthetic SVL9 and SVL10 pep-
tides, representing only the SVVGVWYL and SVVGVWYLL clone was compared with the nonredundant and ex-
pressed sequence tag (EST) data bases at the NCBIresidues respectively, were potent stimulators of the
30NX/B10Z T hybrid in the presence of Db APC. However, GenBank DNA repository. No significant similarities
were found for either the nucleotide or the predictedas observed for endogenously generated ligand (Figure
5B), the SVL9 peptide was about 1000-fold more active amino acid sequence of 47c1 cDNA in the nonredundant
Minor Histocompatibility Gene Products
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Figure 6. Analysis of the Allelic Polymorphism at the H13 LocusFigure 5. Identification of the Anti-H13a T Cell±Stimulating Activity
as the SSVVGVWYL Nonapeptide (A) The PCR expression constructs were generated by amplifying
genomic DNA between the indicated forward and reverse primers.(A) Nucleotide sequence of the antigenic 47c1 fragment and its
Constructs from the B6-H13a and BALB H13b strains were trans-predicted translation (accession numberAF017785). The lines above
fected into Db1 recipient cells, which were then tested as APC forthe sequence show the location of the reverse PCR primers (R4,
stimulating the 30NX/B10Z T cell response. Data shown are repre-R7, R8, and R11) used to generate deletions within this region. The
sentative of one of 18 B6 and 5 BALB PCR constructs tested.residues of the SVL10 and SVL9 peptides are enclosed within boxes
(B) The predicted amino acid sequences of the antigenic regions ofand shaded.
the B6, B10 (H13a) versus the CE/J, LP/J and BALB (H13b) strains.(B) The T cell response to APC transfectedwith the indicated expres-
With the B6 (H13a) sequence as reference, identical residues aresion constructs. The MSVL10 and MSVL9 constructs encode the
shown by dots and substitutions by the single letter code. TheSVL10 and SVL9 residues with a methionine codon for translational
antigenic H13a SVL9 peptide and its H13b homolog SIL9 sequencesinitiation.
are boxed.(C) The response of H13a-specific 30NX/B10Z and H3aa-specific
Lpa/2RZ T cells to the indicated concentration of SVL9 and SVL10
synthetic peptides added to Db-L cells. The conditions for transfec-
tion and measurement of T cell responses were the same as in the both alleles were also found to be transcribed by North-
legends to Figures 1 and 2.
ern blot analysis (data not shown). To assess directly
the antigenic reactivity of these allelic gene products,
PCR primers wereused to amplifygenomic DNA flankingdata base. There was, however, significant similarity
between the 47c1 sequence and several mouse and the region known to encode the H13a antigen from
mouse strains that represent both H13a and H13b haplo-human EST clones (e.g., accession numbers W46128
and AA126873). These ESTs were derived from an array types (see Experimental Procedures). The H13a B6 and
H13b BALB (see below)-derived PCR fragments wereof diverse tissues representing placenta, embryo, adult
brain, retina, thymus, and lymphoid cells. The 47c1 clone subcloned into pcDNAI vector and tested for their ability
to stimulate the H13a-specific 30NX/B10Z T hybrid afterand these ESTs are also similar to hypothetical yeast
and C. elegans 67.5kd and 52.8 kd proteins, respectively transfection into Db recipient cells. Significantly, although
the expected PCR products were obtained from both(accession numbers P34248 and P49049). Thus, 47c1
encodes a novel, widely expressed protein whose only the B6 and the BALB strains, only the PCR constructs
from the B6 strain generated the T cell±stimulating li-known function, as shown here, is to serve as a donor
for the antigenic H13 peptide. gand (Figure 6A). Thus, the antigenic polymorphism of
the H13 alleles could be attributed to variation in their
coding sequences.A Conservative Valine → Isoleucine Substitution
Accounts For Self/Nonself Discrimination To define precisely the amino acid sequence differ-
ences between the H13 a and b alleles, PCR fragmentsat the H13a Locus
What was the explanation for the antigenic polymor- derived from the known H13a strains (B6 and B10) and
H13b strains (B10.CE(30NX) and LP/J) as well as BALB/cphism of the H13 locus? As seen by the Southern blot
analysis above, both the H13a and H13b alleles were were sequenced. Alignment of the predicted amino acid
sequences is shown in Figure 6B. Most significantly,present in the appropriate mouse strains. Furthermore,
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peptide to bind Db, or from a failure of the T cell to
recognize the SIL9/Db complex. To distinguish among
these possibilities, the SIL9 peptide was synthesized
and added exogenously to Db APC, thus obviating the
requirement for processing the endogenous precursor.
Again, in contrast to the high potency of the SVL9 pep-
tide, the SIL9 peptide wasseveral hundred± to a thousand-
fold less active (Figure 7B). To assess whether the differ-
ence in peptide specificity of the T cell response was
due to decreased binding of SIL9 peptide to the Db MHC,
the peptides were tested for their ability to stabilize Db
MHC expression on the surface of TAP2 RMA/S cells.
Significantly, both the SVL9 and the SIL9 peptides were
comparable in their ability to stabilize Db MHC but were
consistently 3- to 10-fold less efficient than the proto-
type Db MHC-binding influenza nucleoprotein (NP) pep-
tide (Figure 7C). The peptide binding to the Db MHC
was specific because the AFV8 peptide that binds Kb
(Malarkannan et al., 1996b) did not stabilize the Db MHC.
Conversely, only the AFV8 peptide stabilized the Kb
MHC, and all three Db binding peptides failed to stabilize
Kb in the same experiment (Figure 7D). Thus, the expla-
nation for the H13a antigenic polymorphism was not a
failure to generate the peptide/Db complexes, but in-
stead the ability of the 30NX/B10Z T cell antigen receptor
to discriminate between the valine versus the isoleucine
side chains, a single methyl group substitution, within
the SVL9 and the SIL9/Db complexes. We subsequently
refer to these ligands collectively as the S[I,V]L9/Db com-Figure 7. Endogenous and Exogenous Antigenic Activity and Db
MHC Binding Capacity of H13a and H13b Antigenic Homologs plexes.
S[I,V]L9
(A) Endogenous generation of the 30NX/B10Z T cell±stimulating The S[I,V]L9 Peptides Are Immunodominant
H13/Db ligand in APC transfected with varying amounts of DNA Epitopes in Reciprocal Anti-H13a/b
encoding the H13a, MSVL9 or H13b, MSIL9 sequences. CTL Responses(B) T cell±stimulating activity of SVL9 versus SIL9 synthetic peptides
Graft rejection and Db-restricted cytotoxic T lymphocytesadded exogenously to Db-L cells as APC.
(CTLs) can be elicited bidirectionally, in the H13a anti-(C, D) The Db and Kb MHC stabilization capacity of SVL9, SIL9, the
influenza NP (ASNENMETM) and the AFV8 (ANYDFICV) peptides H13b and the H13b anti-H13a directions (D. R., unpub-
(Malarkannan et al., 1996b). The TAP-RMA/S cells were incubated lished data). Considering that both S[I,V]L9 peptides
with varying concentrations of the indicated peptides and stained could bind Db, each peptide could serve as a potential
with either the anti-Db or anti-Kb MAb. The NP and AFV8 peptides
T cell receptor (TCR) ligand and thus provide a molecularrespectively serve as reciprocal controls to demonstrate the Db and
explanation for this reciprocal CTL activity. To test thisKb MHC specificity of binding.
hypothesis, CTL responses were elicited in the B10
(H13a) and the B10.CE(30NX)-H13b strains by reciprocal
among the two to four amino acid substitutions found immunization. Bulk CTLs generated in mixed leukocyte
in this region, a single Val→Ile substitution was found culture were tested for their lytic specificity using the
within the SVL9 region (boxed in Figure 6B) and was SVL9, the SIL9, or the NP peptide as a negative control.
consistent with expression of H13 antigen typing among The SVL9 peptide sensitized T2-Db target cells at a sub-
these strains. Presence of this amino acid substitution picomolar concentration for high levels of lysis by bulk
within the H13a residues suggested that this substitution anti-H13a CTL cultures, demonstrating that the CTL ac-
could cause the observed failure of H13b PCR constructs tivity was predominantly directed at the SVL9 epitope
to generate the T cell ligand. To test directly the signifi- (Figure 8A). Again the SIL9 peptide was recognized by
cance of the Val→Ile substitution, the Met SSVIGVWYL the anti-H13a CTL, but at a z300-fold higher concentra-
(MSIL9) expression construct was prepared and tested tion. In repeated experiments, a half-maximal concen-
for activity. However, unlike the highly active MSVL9 tration of SIL9 versus SVL9 peptides for target cell lysis
construct, the MSIL9 construct failed to generate the T by the 30NX anti-B10 CTL ranged between 130- and
cell±stimulating ligand following transfection into Db1 500-fold. Virtually identical results were observed when
recipient cells (Figure 7A). We conclude that a single normal splenic lymphoblasts, rather than T2-Db, were
conservative Val→Ile substitution alone could give rise used as peptide-sensitized target cells (data not shown).
to the H13a antigen. We conclude that the anti-H13a CTLs demonstrate a
The inability of the MSIL9 expressing cells to stimulate strong but not absolute preference for the SVL9 peptide.
the 30NX/B10Z T cell could have resulted from a failure The reciprocal (H13a anti-H13b) immunization also elic-
to generate the SIL9/Db complex via the intracellular ited CTLs that efficiently lysed target cells at a subpico-
molar concentration, but instead with a strong prefer-antigen processing pathway, from an inability of theSIL9
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rather the SVL10 peptide that was also active (Figure
5C), we analyzed the acid soluble peptide pool in the
EL-4 cell line that is derived from the H13a B6 strain
mice. The peptide mixture was fractionated by HPLC
using a reverse phase C18 column, and each fraction
was tested for 30NX/B10Z stimulating activity. This com-
plex peptide pool contained only a single peak of T cell±
stimulating activity that coeluted with the synthetic SVL9
peptide and was clearly distinguishable from the elution
profile of the synthetic SVL10 peptide (Figure 8C). Com-
parison of the activity of the HPLC peak with a standard
curve run in parallel, and based upon control spiking
experiments showing that the experimental recovery of
the SVL9 peptide ranged between 10±50% (data not
shown), showed that EL-4 cells could express at most
45 copies/cell of this peptide. Judging by the somewhat
higher T cell±stimulating activity of EL-4 relative to splenic
blasts (Figure 1), as well as similar amounts of H13a and
H13b transcripts in Northern blots (data not shown), we
expect that the natural abundance of the S[I,V]L9 pep-
tides is not likely to be any higher in normal cells. This
result establishes the congruence between SVL9 and
its naturally processed analog and clearly demonstrates
that rare peptides can serve as minor histocompatibility
antigens.
Discussion
Figure 8. Bulk CTL Responses to H13a and H13b Preferentially Rec-
ognize the SVL9 and SIL9 Peptides, Respectively
Minor histocompatibility (H) loci are known to encode
(A) 30NX/B10-bulk CTLs, elicited by immunization of B10.CE(30NX)- antigens responsible for inducing T cell responses, and
H13b with B10-H13a cells and (B) B10/30NX-bulk CTLs, elicited by
thereby causing GVHD and/or chronic tissue rejectionreciprocal immunization, were analyzed for their lytic specificity with
among individuals with identical MHC molecules. WeT2-Db targets in the presence of varying concentrations of SVL9
and SIL9 peptides. Specific lysis was determined at the indicated show here that the T cell±stimulating activity of the mouse
concentrations of the synthetic peptides at a 10:1 or 20:1 effector- H13 locus is due to the product of a novel chromosome
to-target cell ratio. 2 gene that can be defined solely by the conservative
(C) The naturally processed H13a peptide coelutes with SVL9. A total Val↔Ile substitution within the SSV[I/V]GVWYL (abbrevi-
EL-4 extract was fractionated by HPLC and the fractions assayed
ated as S[I,V]L9) nonapeptide/Db MHC complexes. Thefor the presence of 30NX/B10Z-stimulating activity using Db-L cells
results provide a molecular explanation for how anti-as APC. Mock indicates fractions collected in an identical run with
sample buffer alone prior to the extract sample. The arrows mark genic polymorphism arises as a consequence of allelic
the retention time of SVL9 and SVL10 peptides under identical run variation at a classically defined autosomal minor H locus
conditions. The dashed line indicates the percent acetonitrile con- and further insights into the nature and immunological
centration. role of naturally processed minor H peptides.
ence for the SIL9 over the SVL9 peptide (Figure 8B). The
The H13 Minor Histocompatibility LocusSVL9 peptide that was active at subpicomolar concen-
The products of the numerous autosomal minor H locitrations for anti-H13a CTL was now required at an ap-
have long remained elusive, described at best by theproximately 5000-fold higher concentration to observe
approximate chromosomal locations of their genes orsimilar levels of target cell lysis by the anti-H13b CTL.
as T cell±stimulating antigenic activity in cell extractsAs expected, a CTL clone specific for the unrelated H3aa
(http://www.informatics.jax.org/encyclo.html; Wallny andantigen showed no lytic activity with either the SVL9 or
Rammensee, 1990; Doolittle et al., 1996). Given the enor-the SIL9 peptides (data not shown), and none of the
mous complexity of the naturally processed peptideCTL responded to the NP peptide. We conclude that
pool (Hunt et al., 1992), identifying the active peptideboth the SVL9 and the SIL9 peptide/MHC complexes
by biochemical purification is a daunting task that, evenwere presented efficientlybyAPC invivoandwere capable
when accomplished, does not readily allow identifica-of eliciting CTL responses with reciprocal mirror image
tion of the donor protein if there are no matches in thespecificities. Intriguingly,with bothanti-H13a and anti-H13b
sequence data bases (den Haan et al., 1995; PerreaultCTL, equivalent levels of lysis were obtained with the
et al., 1996). As demonstrated here, expression cloningself-H13 homolog peptides, but at several hundred± to
of the T cell±stimulating antigen genes represents anseveral thousand±fold higher concentrations.
alternative and general strategy for identification of mi-
nor H loci, including those that yield rare peptide/MHCNatural Processing of SVL9 in H13a Cells
complexes. A clear advantage of the expression cloningTo determine the abundance and to establish the iden-
tity of the naturally processed H13 peptide as the SVL9 strategy is that it allows direct identification of the gene
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encoding the minor H peptide without the requirement MHC in the endoplasmic reticulum (ER). In either event,
analysis of how the S[I,V]L9 peptides are generated andfor sophisticated instrumentation or prior knowledge of
its chromosomal location. It is likely that this technique presented by Db MHC should provide additional insights
into the antigen presentation pathway.will facilitate the characterization of other minor H genes
as well (N. S. and D. R., unpublished data).
The H13 locus was originally identified by Snell and
Allelic Polymorphism of H13 Locus and Its Rolecoworkers by the trait of tissue rejection and was func-
in the Immune Responsetionally mapped to the central region of chromosome 2
The similarity between the self and foreign H13 peptidesbetween agouti, a, and another minor H locus, H3 (Snell
is striking. Both allelic S[I,V]L9 homologs bound Db MHCet al., 1967). Our mapping of the 47c1 cDNA in H13
equivalently, stimulated their respective CTLs at similarand H3 congenic strains confirms Snell's chromosomal
concentrations, and elicited potent CTL responses. Thepositioning at the molecular level and rules out an alter-
presence or absence of the single methyl group (valinenative trans-regulation model of genetic control at least
versus isoleucine) in the S[I,V]L9/Db complex thus pro-for the H13 minor antigen locus. Analysis of interspecific
vides the primary structural basis for the self/nonselfbackcross panels described here positioned the H13
discrimination by the T cell repertoire. Interestingly, alocus such that it cosegregated with a. A mouse stock
single conservative amino acid substitution (Ile 6 to Ala)carrying a mutation affecting the a locus was reported
was also found to distinguish the mitochondrial H anti-to reject skin from wild-type mice, suggesting that this
gen alleles, the ND1a and the ND1b peptides presentedmutation could act as an H locus (McKenzie et al., 1985).
by the H2-M3 class 1b MHC molecule (Loveland et al.,While the relationship between this mutant H locus and
1990), and the allelic ATPase6 peptides (Glu to Lys) pre-H13 remains unknown, the lack of any discernible se-
sented by the rat MHC class I (Bhuyan et al., 1997). While itquence similarity between 47c1 cDNA and the a gene
would be tempting to conclude that these substitutionsproduct makes it unlikely that H13 is related to a. The H13
affect T cell specificity because they contact the TCR,locus thus represents a novel protein that, based upon
note that the recently solved crystal structure of the ND1similarity to EST cDNAs, appears to be expressed in di-
peptide/H2-M3 structure showed that the variant p6 Ileverse mammalian tissues and may also have homologs
residue was solvent inaccessible (Wang et al., 1995a).in other species. Although the only known function of
Thus, amino acid substitutions in the antigenic peptidethe H13 protein is to serve as a donor for the SVL9/Db
could also affect specificity of the T cell response with-complex, the availability of the cDNA clone should allow
out directly contacting the TCR. Because the S[I,V]L9elucidation of its other cellular functions as well.
peptides lack the Db consensus motif, the rules of sol-
vent accessibility of individual side chains based upon
the recently solved crystal structures of the NP peptide/DbThe H13/Db Peptide Complex
The H13 nonapeptides S[I,V]L9 differ from all other pep- complex (Young et al., 1994) cannot be extrapolated to
predict the orientation and presumed TCR accessibilitytides known to be presented by the Db MHC molecule
(Brusic et al., 1996). Previously defined antigenic pep- of the p4 Val versus the Ile residues. This problem can,
however, be resolved by determining the crystal struc-tides, such as those from the influenza nucleoprotein,
ASNENMETM (Falk et al., 1991a), the SV40 large T anti- tures of the S[I,V]L9/Db complexes.
A number of hypotheses have been proposed to ex-gen, CKGVNEEYL (Lill et al., 1992), or the HY peptide,
WMHHNMDLI (Greenfield et al., 1996), all share the non- plain the immunogenicity of minor H gene products
(reviewed in Lindahl, 1991; Roopenian, 1992; Goulmy,amer consensus motif XXXX[N]XXX[ I,L,M ] defined by
sequencing a mixture of Db-bound peptides (Falk et al., 1996). The simplest of these falls under the rubric of
determinant selection, in which amino acid substitutions1991b). However, as shown here by the existence of
S[I,V]L9/Db complexes, the consensus motif clearly fails in theH gene product in the donor strain cause presenta-
tion of novel minor H peptide/MHC complexes that areto predict all peptides that can specifically bind Db MHC
and stimulate potent T cell responses. Given that the absent in the recipient strain and therefore immuno-
genic. This model does explain the mouse HY-specificconsensus motif was identified by sequencing a mixture
containing thousands of different peptides, it represents T cell response: female mice not only lack the Y chro-
mosome±derived Uty- and Smcy-derived peptide/MHConly the most abundant peptides that survive the isola-
tion procedure and are amenable to microsequencing complexes but also fail to present homologous peptides
(encoded by the X chromosome homologs Utx andprocedures. Peptides such as S[I,V]L9, which are rare
and appear to bind Db MHC less well, may not be recov- Smcx), due to a deletion or a lack of MHC binding (Scott
et al., 1995; Greenfield et al., 1996). The same modelered in sufficient amounts to yieldstrong signalscharac-
teristic of the asparagine anchor residue in the Db motif. may also be applicable to the Smcy-encoded T cell
epitopes in humans (Wang et al., 1995b; Meadows etNote that the anchor residue(s) of the S[I,V]L9 peptides
are not yet known, and it remains to be determined al., 1997). The male cell surface is thus unambiguously
foreign to the female T cells.whether they define an alternate set of peptides with a
novel consensus motif. Curiously, the H13a antigen is Unlike the mechanism of antigenic polymorphism at
the HY loci, T cell recognition of the allelic H13 peptidesalso expressed well in TAP2 RMA/S cells (D. C. R., un-
published observations), suggesting the interesting pos- lies on the cusp of foreign- versus self-reactivity. Al-
though both anti-H13a and anti-H13b CTL clearly pre-sibility that the H13 precursor could be processed in a
manner distinct from conventional cytoplasmic precur- ferred the foreign peptide, they also cross-reacted with
the self-H13 homologs (Figure 8). In particular, for thesors and may yield atypical peptides for binding to Db
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F1/5R-5 (formerly C2) have been described (Roopenian and Davis,anti-H13a CTL, equivalent levels of lysis were observed
1989). All CTL lines were maintained by weekly stimulation with B10with the foreign SVL9 and the self-SIL9 peptide at a few
or B6 spleen cells and 10±30 U/ml recombinant interleukin-2 (rIL-2)hundred±fold higher concentration. The S[I,V]L9 pep-
using established conditions (Roopenian and Davis, 1989). The cor-
tides should therefore beconsidered partial and recipro- responding lacZ inducible T cell hybrids, 30NX/B10Z, Lpa/2RZ, and
cal agonists that define the limits of negative selection. F1/5R-5Z, were generated by fusing the CTL lines with the BWZ.36/
CD8a fusion partner as described (Sanderson and Shastri, 1994).Given that T cell activation requires the presence of only
The anti-H-2b alloreactive 18.5Z T cell hybrid has been previouslya few peptide/MHC complexes (Kageyama et al., 1995;
described (Malarkannan et al., 1995a). To generate H13b anti-H13aMalarkannan et al., 1996a), the escape from negative
CTL, B10.CE(30NX)-H13b/Sn mice were primed twice with 2 3 107selection of the anti-H13 TCRs would be possible only if
spleen cells from male B10 mice and then restimulated for 5±6 days
the natural abundance of the self-S[I,V]L9/Db complexes with spleen cells from 200 Gy-irradiated mice in DMEM medium
remained below z100±1000 copies/cell. The measure- supplemented on day 3 of culture with 10±30 U/ml rIL-2 as described
(Roopenian et al., 1993). 30NX/B10-bulk is a cryopreserved pool ofment of naturally processed SVL9 peptide at z50 cop-
four such MLCs used after a 6-day expansion with B10 spleen cellsies/cell is in accordance with this expectation. Whether
and 30 U/ml rIL-2. To generate H13a anti-H13b CTL, female B10 miceexceeding this ªsafe limitº will cause H13-specific toler-
were primed with male B10.CE(30NX)-H13b/Sn spleen cells and thenance or autoimmunity remains an interesting question.
grafted with tail skin from female B10.CE(30NX)-H13b/Sn mice. When
The existence of partial H13 agonists also suggests rejection of grafts was occurring, peripheral blood leukocytes were
another role for autosomal peptides during development obtained from retro orbital blood, purified, and cultured in MLC with
irradiated female 30NX cells and 30 U rIL-2 for 9 days as describedof the T cell repertoire that could explain their potent
(Roopenian et al., 1993). B10/30NX-bulk is such a culture restimu-immunogenicity. The expression of H13 transcripts in
lated once after MLC with irradiated 129/J (H13b) cells and 30 U/mlthe spleen as well as in the thymus (data not shown)
rIL-2.provides an opportunity for the S[I,V]L9/Db complexes
to participate in positive selection of the TCR repertoire T Cell Activation Assays
as well. Thus, as demonstrated in model systems, pep- T cell responses specific for peptide/MHC were measured by the
tide-specific, low affinity interactions with the self-H13 production of b-galactosidase activity in the T cell hybrids (Karttunen
and Shastri, 1991; Sanderson and Shastri, 1994). T hybrids (3±10 3 104)peptide/Db complex could favor positive selection of
were cocultured overnight with APC (2±5 3 104) either expressingTCRs specific for the alternative allelic homolog (Ash-
the antigen endogenously, transfected with antigen cDNAs, or withton-Rickardt et al., 1993; Hogquist et al., 1994, 1997;
exogenouspeptides in 96-wellplates. The peptide/MHC-inducedT cell
Sebzda et al., 1994; Pawlowski et al., 1996), which in turn response was determined using the b-galactosidase substrate chlo-
could impact upon the frequency and/or TCR affinity of rophenol red b-galactoside (CPRG) as described (Sanderson and
the precursor CTLs that emerge. Such a scenario might Shastri, 1994). The conversion of CPRG to chlorophenol red was
measured at 595 nm and 655 nm as a reference wavelength with aexplain why T cell responses to single autosomal minor
96-well microplate reader (BioRad, Richmond, CA). Data show theH antigens are high in magnitude and why responses
mean absorbence of replicate cultures and are representative of atto ªmerely foreignº HY antigens can be readilycompeted
least three independent experiments. Chromium release assays for
out by the autosomal ªneo-selfº H antigens (Wettstein, CTL activity were a modification of that described earlier (Roopenian
1986). This novel hypothesis as well as the role of minor et al., 1983). Peptide pulsed target cells T2-Db were prepared by
H antigens in tissue rejection reactions can now be ex- adding 2±5 3 104 51Cr-labeled target cells to V-bottom microtiter
wells with varying peptide concentrations for 1 hr. Effector cellsamined directly.
were then added at an effector-to-target ratio of 10:1 or 20:1 and
incubated for 4 hr. Percent specific lysis was calculated from theExperimental Procedures
amount of 51Cr released into the culture supernatant and is shown
as the mean of triplicate cultures.Mice
All the indicated inbred mouse strains were obtained from or bred
cDNA Library and Expression Screensat The Jackson Laboratory (Bar Harbor, ME). (BALB/c 3 BALB.B)F1
A unidirectional cDNA library was constructed (Superscript Choicemice were bred in the animal care facility at the University of Califor-
System, GIBCO-BRL) using poly (A)1 mRNA from EL4 cells in thenia (Berkeley, CA) from Jackson Laboratory stocks.
BstXI±NotI sites of the mammalian expression vector pcDNA1 (In-
vitrogen, San Diego, CA; Malarkannan et al., 1995a, 1996a). TheCell Lines
cDNAs were screened by transforming competent bacteria withCell lines were maintained in RPMI 1640 medium (GIBCO-BRL,
recombinant plasmids and culturing in pools of z30±100 cfu in 96-Grand Island, NY) supplemented with 2 mM glutamine, 1 mM pyruvate,
well U-bottom plates. For expression screens, aliquots of cDNA50 mM b-mercaptoethanol,100 U/ml penicillin, 100 mg/ml streptomy-
(50±100 cfu/well) prepared directly in the 96-well plates were tran-cin, and 10% fetal bovine serum (FBS; Hyclone, Logan, UT) or in
siently transfected into 3 3 104 LMtk cells cotransfected with theDulbecco's modified Eagle's medium (DMEM) supplemented as
relevant MHC class I cDNA (10 ng/ml) and B7-2 cDNA (5 ng/ml).described (Cerottini et al., 1974). LMtk-(C3H, H-2k) and its MHC-
Two days later, 10 3 104 30NX/B10Z T cells were added per wellexpressing transfectant derivatives have been described previously
and cocultured overnight. Positive pools were identified by adding(Shastri et al., 1985). The DbL-B7 transfectant was generated by
CPRG and scoring pools with above background absorbence. Thetransfection of DbL with a B7±2 cDNA construct (a gift from J. Allison,
single plasmid encoding the antigenic activity was identified byUniversity of California, Berkeley, CA) and selection with 1 mg/ml
repeating the screen with individual colonies obtained from the posi-G418. EL4-B7 (H-2b), RMA (H-2b), and its TAP-derivative RMA/S cell
tive cDNA pool. The sequence of 47c1 cDNA is available from thelines were obtained from Drs. J. Allison and D. Raulet (University of
NCBI GenBank with the accession number AF017785.California, Berkeley, CA). T2-Db cells were a kind gift of P. Cresswell
(Yale University, New Haven, CT). Splenic blasts were made by
stimulating spleen cells for 2 days with 4 mg/ml concanavalin A and Expression Constructs and Peptides
Deletion constructs were generated by amplifying 47c1 DNA with30 mg/ml lipopolysaccharide. The H13a-specific 30NX/B10±1 clone
CTL line was generated by immunizing the B10.CE (30NX)-H13b/Sn a vector-specific forward primer and a 47c1 reverse primer R4 (59-
CTGCCCTTGTCAGCCCAACCTC-39), R7 (59-TCAGAAGGTACCAGmice with cells from the B10-H13a (H13a) mice as described (Cariappa
et al., 1996). The H3aa-specific, Db-restricted cloned CTL line Lpa/2R-1 ACACCA-39), R8 (59-AGTGTCAAACTCATAGTTGA-39), or R11 (59-
TAGGCCCAGGCACACCAGGT-39) using Pfu polymerase (Stratagene,(formerly C1) and the Kb-restricted b2Mb-specific cloned CTL line
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La Jolla, CA). PCR fragments were digested with BamHI in the 59 peptide standard curve and recovery estimates from spiking cells
with a known amount of peptide and back-extraction.flanking region of the vector and cloned into the BamHI±EcoRV sites
of pcDNA1. The F1DR1 construct was made similarly except that
F1 (59-TACCGAGCTCGGATCCCTCTGCTTATGAAACGTTAC-39) con- Acknowledgments
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